Advanced in Testicular Failure

Daniele Gianfrilli

Rome, IT 
Advanced in Testicular Failure
Rome, IT 
OverviewLocationsClinical Research

Overview

Daniele Gianfrilli practices in Rome, Italy. Ms. Gianfrilli is rated as an Advanced expert by MediFind in the treatment of Testicular Failure. Her top areas of expertise are Hypogonadism, Klinefelter Syndrome, Leydig Cell Testicular Tumor, Hormone Replacement Therapy (HRT), and Orchiectomy.

Her clinical research consists of co-authoring 135 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Testicular Failure.

Gender
Female

Locations

Rome, Italy
Other Locations
Latina, Italy
Sapienza, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Study on New Insights in Remodeling of Endocrine Cardiomyopathies: Intramyocardial, Molecular and Neuroendocrine Assessment in Response to Chronic Inhibition of Cyclic GMP Phosphodiesterase 5A in Cushing's Syndrome
Study on New Insights in Remodeling of Endocrine Cardiomyopathies: Intramyocardial, Molecular and Neuroendocrine Assessment in Response to Chronic Inhibition of Cyclic GMP Phosphodiesterase 5A in Cushing's Syndrome
Enrollment Status: Completed
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Tadalafil
Study Phase: Phase 2
Study on New Insights in Remodeling of Endocrine Cardiomyopathies: ASsessmentt of Intramyocardial, Molecular and NeUroendocrine Parameters in Response to Chronic Inhibition of Cyclic GMP Phosphodiesterase 5A in AcroMegaly
Study on New Insights in Remodeling of Endocrine Cardiomyopathies: ASsessmentt of Intramyocardial, Molecular and NeUroendocrine Parameters in Response to Chronic Inhibition of Cyclic GMP Phosphodiesterase 5A in AcroMegaly
Enrollment Status: Completed
Publish Date: May 12, 2023
Intervention Type: Drug
Study Drug: Tadalafil
Study Phase: Phase 2
View 1 Less Clinical Trial

135 Total Publications

Environmental and lifestyle factors and risk of thyroid carcinoma: a cross-sectional study.
Environmental and lifestyle factors and risk of thyroid carcinoma: a cross-sectional study.
Journal: Endocrine
Published: July 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Gianfrilli's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 45 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile